Neutrophil-Lymphocyte Ratio as a Screening Test for Preeclampsia in the First and Early-Third Trimesters of Pregnancy: A Cohort Study
DOI:
https://doi.org/10.31661/gmj.v11i.2433Keywords:
Neutrophils, Lymphocytes, Preeclampsia, Gestation, HypertensionAbstract
Background: Preeclampsia (PEC), affecting 5-10% of all pregnancies, is a multisystem disease diagnosed by hypertension (HTN) and protein in the urine or multi-organ problems without signs of proteinuria occurring after 20 weeks of gestation. PEC is the most common cause of maternal death and can lead to premature delivery. The current study aimed to investigate the accuracy of neutrophil-lymphocyte ratio (NLR) for predicting PEC in the first and early-third trimesters of pregnancy in a normal population in the south of Iran. Materials and Methods: A large-scale cohort study was performed from early pregnancy onward during November 2018-2019 in a normal population from Fars province, Southwest Iran. Four hundred forty-nine pregnant women were followed prospectively, and normal blood pressure (normotensive), gestational HTN, and PEC groups were compared in terms of white blood cells (WBC) count, neutrophil, lymphocyte, and NLR. Results: The serum levels of WBC count, neutrophil, and NLR significantly increased from the first to the early-third trimesters of pregnancy (P<0.05); however, lymphocytes decreased (P<0.05). The NLR cut-off points for predicting PEC were 2.79 (sensitivity=86.7% and specificity=92.6%) in the first and 3.2 (sensitivity=90.5% and specificity=79.4%) in the early-third trimesters. Conclusion: Our findings revealed that NLR could be an accurate predictive factor for PEC in the first and early-third trimesters of pregnancies; however, more studies are needed to investigate the immunomodulatory drugs for the prevention of PEC.
References
The American College of Obstetricians and Gynecologists. New Guidelines in Preeclampsia Diagnosis and Care Include Revised Definition of Preeclampsia. Washington: The American College of Obstetricians and Gynecologists; 2013. Foo L, Tay J, Lees CC, McEniery CM, Wilkinson IB. Hypertension in pregnancy: natural history and treatment options. Curr Hypertens Rep. 2015;17(5):36. https://doi.org/10.1007/s11906-015-0545-1PMid:25833457 Main EK, McCain CL, Morton CH, Holtby S, Lawton ES. Pregnancy-related mortality in California: causes, characteristics, and improvement opportunities. Obstet Gynecol. 2015;125(4):938-47. https://doi.org/10.1097/AOG.0000000000000746PMid:25751214 Fox A, McHugh S, Browne J, Kenny LC, Fitzgerald A, Khashan AS, et al. Estimating the Cost of Preeclampsia in the Healthcare System: Cross-Sectional Study Using Data From SCOPE Study (Screening for Pregnancy End Points). Hypertension. 2017;70(6):1243-9. https://doi.org/10.1161/HYPERTENSIONAHA.117.09499PMid:29084880 Steegers EA, Von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. The Lancet. 2010;376(9741):631-44. https://doi.org/10.1016/S0140-6736(10)60279-6PMid:20598363 Boeldt DS, Bird IM. Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia. J Endocrinol. 2017;232(1):R27-44. https://doi.org/10.1530/JOE-16-0340PMid:27729465 PMCid:PMC5115955 Hansen AT, Bernth Jensen JM, Hvas AM, Christiansen M. The genetic component of preeclampsia: A whole-exome sequencing study. PLoS One. 2018;13(5):e0197217. https://doi.org/10.1371/journal.pone.0197217PMid:29758065 PMCid:PMC5951572 Michita RT, Kaminski VL, Chies JAB. Genetic Variants in Preeclampsia: Lessons From Studies in Latin-American Populations. Front Physiol. 2018;9:1771. https://doi.org/10.3389/fphys.2018.01771PMid:30618791 PMCid:PMC6302048 Stojanovska V, Zenclussen AC. Innate and adaptive immune responses in HELLP syndrome. Front Immunol. 2020;11:667. https://doi.org/10.3389/fimmu.2020.00667PMid:32351511 PMCid:PMC7174768 Walsh SW, Nugent WH, Archer KJ, Al Dulaimi M, Washington SL, Strauss JF. Epigenetic Regulation of Interleukin-17-Related Genes and Their Potential Roles in Neutrophil Vascular Infiltration in Preeclampsia. Reprod Sci. 2022;29(1):154-62. https://doi.org/10.1007/s43032-021-00605-3PMid:33959890 Poon LC, Sahota D. Screening and prevention of preeclampsia. Matern Fetal Med. 2019;1(1):25-30. https://doi.org/10.1097/FM9.0000000000000005 Li L, Zheng Y, Zhu Y, Li J. Serum biomarkers combined with uterine artery Doppler in prediction of preeclampsia. Exp Ther Med. 2016;12(4):2515-20. https://doi.org/10.3892/etm.2016.3625PMid:27698752 PMCid:PMC5038468 Çintesun E, Incesu Çintesun FN, Ezveci H, Akyürek F, Çelik Ç. Systemic inflammatory response markers in preeclampsia. J Lab Physicians. 2018;10(3):316-9. https://doi.org/10.4103/JLP.JLP_144_17PMid:30078969 PMCid:PMC6052816 Ghelfi AM, Lassus MN, Diodati S, Hails EA. [Utility of the neutrophil/lymphocyte ratio and the polymorphonuclear/ monomorphonuclear ratio, in the prediction of preeclampsia]. Hipertens Riesgo Vasc. 2019;36(2):63-9. https://doi.org/10.1016/j.hipert.2018.06.001PMid:30031675 Kang Q, Li W, Yu N, Fan L, Zhang Y, Sha M, et al. Predictive role of neutrophil-to-lymphocyte ratio in preeclampsia: A meta-analysis including 3982 patients. Pregnancy Hypertens. 2020;20:111-8. https://doi.org/10.1016/j.preghy.2020.03.009PMid:32279029 Mannaerts D, Heyvaert S, De Cordt C, Macken C, Loos C, Jacquemyn Y. Are neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and/or mean platelet volume (MPV) clinically useful as predictive parameters for preeclampsia? J Matern Fetal Neonatal Med. 2019;32(9):1412-9. https://doi.org/10.1080/14767058.2017.1410701PMid:29179639 Örgül G, Aydın Haklı D, Özten G, Fadiloğlu E, Tanacan A, Beksaç MS. First trimester complete blood cell indices in early and late onset preeclampsia. Turk J Obstet Gynecol. 2019;16(2):112-7. https://doi.org/10.4274/tjod.galenos.2019.93708PMid:31360585 PMCid:PMC6637787 Sitotaw C, Asrie F, Melku M. Evaluation of platelet and white cell parameters among pregnant women with Preeclampsia in Gondar, Northwest Ethiopia: A comparative cross-sectional study. Pregnancy Hypertens. 2018;13:242-7. https://doi.org/10.1016/j.preghy.2018.06.006PMid:30177059 Wang J, Zhu QW, Cheng XY, Liu JY, Zhang LL, Tao YM, et al. Assessment efficacy of neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in preeclampsia. J Reprod Immunol. 2019;132:29-34. https://doi.org/10.1016/j.jri.2019.02.001PMid:30861482 Hai L, Hu Z-D. The clinical utility of neutrophil to lymphocyte ratio in pregnancy related complications: a mini-review. J Lab Precis Med. 2020;5(1):1-9. https://doi.org/10.21037/jlpm.2019.10.03 Mannaerts D, Heyvaert S, De Cordt C, Macken C, Loos C, Jacquemyn Y. Are neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and/or mean platelet volume (MPV) clinically useful as predictive parameters for preeclampsia? J Matern Fetal Neonatal Med. 2019;32(9):1412-9. https://doi.org/10.1080/14767058.2017.1410701PMid:29179639 Mayrink J, Souza RT, Feitosa FE, Rocha Filho EA, Leite DF, Vettorazzi J, et al. Incidence and risk factors for Preeclampsia in a cohort of healthy nulliparous pregnant women: a nested case-control study. Sci Rep. 2019;9(1):1-9. https://doi.org/10.1038/s41598-019-46011-3PMid:31266984 PMCid:PMC6606578 Bodnar LM, Simhan HN, Catov JM, Roberts JM, Platt RW, Diesel JC, et al. Maternal vitamin D status and the risk of mild and severe preeclampsia. Epidemiology. 2014;25(2):207-14. https://doi.org/10.1097/EDE.0000000000000039PMid:24457526 PMCid:PMC4053531 Panwar M, Kumari A, Hp A, Arora R, Singh V, Bansiwal R. Raised neutrophil lymphocyte ratio and serum beta hCG level in early second trimester of pregnancy as predictors for development and severity of preeclampsia. Drug Discov Ther. 2019;13(1):34-7. https://doi.org/10.5582/ddt.2019.01006PMid:30880320 Avci B, Avci A, Dönmez Y, Kaya A, Gülen M, Özer A, et al. The Effectiveness of Neutrophil-Lymphocyte Ratio in Predicting in-Hospital Mortality in Non-ST-Elevation Myocardial Infarction. Emerg Med Int. 2020;2020:8718304. https://doi.org/10.1155/2020/8718304PMid:32211208 PMCid:PMC7085368 Hajibandeh S, Hajibandeh S, Hobbs N, Mansour M. Neutrophil-to-lymphocyte ratio predicts acute appendicitis and distinguishes between complicated and uncomplicated appendicitis: A systematic review and meta-analysis. Am J Surg. 2020;219(1):154-63. https://doi.org/10.1016/j.amjsurg.2019.04.018PMid:31056211 Phan T, Brailovsky Y, Fareed J, Hoppensteadt D, Iqbal O, Darki A. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict All-Cause Mortality in Acute Pulmonary Embolism. Clin Appl Thromb Hemost. 2020;26:1076029619900549. https://doi.org/10.1177/1076029619900549PMid:31960711 PMCid:PMC7098206 Yin X, Wu L, Yang H, Yang H. Prognostic significance of neutrophil-lymphocyte ratio (NLR) in patients with ovarian cancer: A systematic review and meta-analysis. Medicine (Baltimore). 2019;98(45):e17475. https://doi.org/10.1097/MD.0000000000017475PMid:31702609 PMCid:PMC6855616 Vecchié A, Bonaventura A, Carbone F, Maggi D, Ferraiolo A, Carloni B, et al. C-reactive protein levels at the midpregnancy can predict gestational complications. Biomed Res Int. 2018;2018:1070151. https://doi.org/10.1155/2018/1070151PMid:30533423 PMCid:PMC6247639 Gomes VJ, Nunes PR, Matias ML, Ribeiro VR, Devides AC, Bannwart-Castro CF, et al. Silibinin induces in vitro M2-like phenotype polarization in monocytes from preeclamptic women. Int Immunopharmacol. 2020;89:107062. https://doi.org/10.1016/j.intimp.2020.107062PMid:33045562 Kurt RK, Aras Z, Silfeler DB, Kunt C, Islimye M, Kosar O. Relationship of red cell distribution width with the presence and severity of preeclampsia. Clin Appl Thromb Hemost. 2015;21(2):128-31. https://doi.org/10.1177/1076029613490827PMid:23728834 Yavuzcan A, Caglar M, Ustun Y, Dilbaz S, Yidiz E, Ozbilgec S, et al. Mean platelet volume, neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in severe preeclampsia. Ginekol Pol. 2014;85(3):197-203. https://doi.org/10.17772/gp/1713 AKIL MA, Bilik MZ, Acet H, Tunç SY, Ertaş F, AYDIN M, et al. Mean platelet volume and neutrophil lymphocyte ratio as new markers of preeclampsia severity. Koşuyolu Heart Journal. 2015;18(2): 84-8. https://doi.org/10.5578/khj.9852 Kirbas A, Ersoy AO, Daglar K, Dikici T, Biberoglu EH, Kirbas O, et al. Prediction of Preeclampsia by First Trimester Combined Test and Simple Complete Blood Count Parameters. J Clin Diagn Res. 2015;9(11):Qc20-3. https://doi.org/10.7860/JCDR/2015/15397.6833PMid:26674673 PMCid:PMC4668480 Serin S, Avcı F, Ercan O, Köstü B, Bakacak M, Kıran H. Is neutrophil/lymphocyte ratio a useful marker to predict the severity of pre-eclampsia? Pregnancy Hypertens. 2016;6(1):22-5. https://doi.org/10.1016/j.preghy.2016.01.005PMid:26955767 Kurtoglu E, Kokcu A, Celik H, Tosun M, Malatyalioglu E. May ratio of neutrophil to lymphocyte be useful in predicting the risk of developing preeclampsia? A pilot study. J Matern Fetal Neonatal Med. 2015;28(1):97-9. https://doi.org/10.3109/14767058.2014.905910PMid:24635498 Oylumlu M, Ozler A, Yildiz A, Oylumlu M, Acet H, Polat, N, et al. New inflammatory markers in pre-eclampsia: echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio. Clin Exp Hypertens. 2014;36(7):503-7. https://doi.org/10.3109/10641963.2013.863324PMid:24433091 Canzoneri BJ, Lewis DF, Groome L, Wang Y. Increased neutrophil numbers account for leukocytosis in women with preeclampsia. Am J Perinatol. 2009;26(10):729-30. https://doi.org/10.1055/s-0029-1223285PMid:19452432 PMCid:PMC3062252 Terrone DA, Rinehart BK, May WL, Moore A, Magann EF, Martin Jr JN. Leukocytosis is propor-tional to HELLP syndrome severity: evidence for an inflammatory form of preeclampsia. South Med J. 2000;93(8):768-71. https://doi.org/10.1097/00007611-200008000-00005https://doi.org/10.1097/00007611-200093080-00005PMid:10963506
